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A B S T R A C T
Owing to their versatile chemistry, polyaspartamides have recently attracted increased interest in various bio-
medical uses such as drug delivery systems and scaffolding materials. Solubility of these polymers in organic
solvents and in water at certain values of pH can be fine-tuned by their chemical composition, which was
exploited here to fabricate fast-dissolving electrospun matrices in ethanol with no additives. Various side groups
were tested to control the solubility of the polymers as well as the morphology and moisture uptake of the
matrices produced. Tertiary amine groups were immobilized to ensure high solubility around neutral pH, while
modification with alkyl side groups limited moisture uptake. Finally, 3-(diethylamino)propyl and n-butyl side
groups were used in equal amounts. The effect of viscosity, surface tension and specific conductivity of polymer
solutions on the fiber morphology was determined in order to optimize the conditions for preparing fibers with a
narrow size distribution and large specific surface area. The polymer withstood the electrospinning process
without any chemical degradation, as determined by IR, and was thermally stable. Furthermore, the matrices
exhibited a glass transition temperature above room temperature. The complete release of vitamin B12 was
observed within one minute due to the fast dissolution of the matrices in simulated salivary fluid at pH = 6.8,
supporting the potential of the developed materials in oral drug delivery.
1. Introduction
Oral transmucosal (sublingual and buccal) drug delivery can sub-
stantially increase the bioavailability of drugs by their rapid absorption
through the mucous membranes of the oral cavity. The drugs absorbed
by this route are not exposed to degradation in the gastrointestinal tract
and the hepatic first-pass metabolism is bypassed [1,2]. Commercially
available formulations do not exploit the full potential of the oral
transmucosal route, which has directed considerable attention towards
electrospun polymer matrices with micro or nanofibrous morphology
[3–5]. The large specific surface area of electrospun matrices provides
fast dissolution and rapid drug release, while the rate can be controlled
by the morphology of the fibers. The shape and diameter of the fibers
can be tailored both through the properties of the pre-cursor material
(polymer composition, concentration, dielectric constant of the solvent,
etc.) and the technological parameters of the electrospinning (applied
voltage, flow rate, etc.) [6–8]. Drug molecules can be loaded into the
matrices in their amorphous state, which further helps their rapid dis-
solution in aqueous medium [9,10]. Finally, contrary to sprays, sus-
pensions or drops; the drugs can easily be administered in an exact dose
from electrospun matrices.
Electrospun materials are mainly prepared from synthetic polymers
such as poly(meth)acrylates, poly(vinyl alcohol), poly(vinyl acetate)
and polyvinylpyrrolidone, but also from natural and natural based
polymers such as cellulose derivatives and poly(lactic acid).
Electrospinning of these polymers commonly requires the use of toxic
or corrosive solvents, which should be avoided in pharmaceutical ap-
plications. Dimethylformamide, chloroform and dichloromethane are
commonly used [11,12], despite the fact that their residual quantities
are strictly limited in pharmaceutical products (ICH Class 2 solvents,
concentration limit ~10 ppm [13,14]). The problem can be overcome
potentially by the use of aqueous medium or melt electrospinning [15],
but these methods cannot be applied for hydrolytically or thermally
unstable drugs as well as molecules with low aqueous solubility [16].
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Ethanol, a green solvent (ICH Class 3, concentration limit: ~5000 ppm
[13,17]), can extend the application of electrospinning for pharma-
ceutical purposes, however the range of available ethanol soluble
polymers is quite limited. The proper derivatization of poly(meth)ac-
rylates [18,19], polyvinylpyrrolidone [20,21], poly(ethylene oxide)
[9,22], poly(vinyl acetate) [23] or hydroxypropyl cellulose [24] in-
volves complex synthetic pathways and most of these polymers lack
biodegradability. Consequently, the use of a biocompatible, biode-
gradable polymer with facile functionalization can open new possibi-
lities in electrospinning from ethanol.
In recent years, polypeptides have attracted particular attention in
electrospinning technology, especially in electrospun matrices for bio-
medical applications [25]. Natural polypeptides, such as gelatin, col-
lagen and silk have the benefits of preparation from renewable sources
and excellent cellular compatibility [26,27]. However, the structure of
these polymers is variable and their chemical modification is difficult.
Moreover, toxic and hazardous solvents (fluorinated alcohols and acids,
dichloromethane) [28] and additional polymers (PEO, PCL) are re-
quired to obtain uniform and bead-free fibers from polypeptides [29].
Drawbacks of natural polypeptides can be overcome by employing
synthetic poly(amino acid)s and analogues of polypeptides. Poly-
succinimide [30–32], poly(γ-glutamic acid) [33] and poly(2-oxazoline)
[34] have already been used, but apart from them, poly(aspartic acid)
(PASP) derivatives also provide the chemical versatility needed for
electrospinning in various solvents. The precursor polymer of PASP,
polysuccinimide (PSI) reacts with primary amines under mild reaction
conditions [35–39], which is of great interest for biomedical applica-
tions of PASP derivatives [40–42].
In our work, we prepared cationic polyaspartamides for electro-
spinning, as these polyaspartamides are highly soluble in water over a
wide pH range, including that of the oral cavity (pH = 6.8), and are
also soluble in pharmaceutically accepted alcohols (ICH Class 3,
[13,17]), such as ethanol and 2-propanol [36]. These polymers were
proven to be low-toxic on different cell lines [43] and, owing to their
polypeptide structure, they are expected to be biodegradable [40]. Al-
though there are some reports on the synthesis of cationic poly-
aspartamides [44,45], no attempt has been made to electrospin cationic
polyaspartamides yet. The few reported fibrous matrices prepared from
PASP derivatives were electrospun from toxic ICH Class 2 solvents,
dimethylformamide or chloroform [30–32,46,47].
Our aim was to prepare cationic polyaspartamide matrices with
rapid dissolution at the pH of the oral cavity. The polymer was syn-
thesized by reacting polysuccinimide (PSI) with 3-(diethylamino)pro-
pylamine, and then with n-butylamine (DEP50B50). The chemical
structure was confirmed by 1H NMR and FTIR spectroscopy. The
polymer was electrospun from ethanol. The viscosity, the surface ten-
sion and the specific conductivity of the polymer solutions were de-
termined to select the proper conditions for electrospinning. The mor-
phology of the nanofiber matrices was investigated by scanning
electron microscopy (SEM). The glass transition temperature (Tg) of the
matrices was determined by differential scanning calorimetry (DSC),
and the thermal decomposition temperature (Td) was characterized by
thermogravimetric analysis (TGA). The dissolution kinetics of the
polymer matrix and the drug release kinetics were determined to de-
monstrate a possible application of the matrix as a sublingual delivery
system.
2. Experimental
2.1. Materials
2-(dimethylamino)ethylamine (DME, 98%), 2-(diethylamino)ethy-
lamine (DEE, 99%), 3-(dimethylamino)propylamine (DMP, 98%),
phosphoric acid (99%), L-tryptophan methyl ester hydrochloride (T),
triethyl citrate (TEC, 98%), DMSO-d6 and vitamin B12 were purchased
from Sigma–Aldrich. L-aspartic acid (99%), 3-(diethylamino)propyla-
mine (DEP, 98%), n-butylamine (B, 99%), dibutylamine (DBA, 99%),
potassium chloride (99.5%), disodium hydrogen phosphate dihydrate
(99.5%), potassium dihydrogen phosphate (99.5%) and dimethyl sulf-
oxide (DMSO, 99.9%) were obtained from Merck. Hydrochloric acid
(HCl, 35%) and ethyl acetate (EtAc, 99.9%) were bought from LachNer.
N,N-dimethylformamide (99.9%) and ethanol (99.7%) was purchased
from Reanal. Saliva was simulated by a pH = 6.8 phosphate buffer
[simulated salivary fluid (SSF), I = 0.15 M]. The pH of the buffer so-
lution was checked with a pH/ion analyzer (Radelkis OP 271/1). All
reagents were used without further purification unless otherwise noted.
Ultrapure water (ρ > 18.2 MΩ cm, Millipore) was used for the pre-
paration of aqueous solutions. Experiments were performed at room
temperature (T = 25 °C) unless otherwise indicated.
2.2. Synthesis and preparation
2.2.1. Synthesis of the cationic polyaspartamides
Polysuccinimide (PSI) was synthesized by thermal polycondensa-
tion of L-aspartic acid in a solvent-free reaction using phosphoric acid
as a catalyst [36]. The synthesis was carried out in a rotary evaporator,
the temperature and pressure being maintained at 200 °C and 10 mbar
during the reaction. A slightly brown product was formed after 5 h. PSI
was purified by precipitation in DMF–H2O (1:3) and dried in vacuum at
25 °C for 24 h. 1H NMR (300 MHz, DMSO-d6, δ) [ppm]: 5.27 (1H,
CO–CH–CH2–CO); 3.22 and 2.74 (2H, CO–CH–CH2–CO). The viscosity
average molecular weight was 29 kDa, determined by viscometry using
an Anton Paar Lovis 2000 rolling ball viscometer [36].
In a typical procedure PSI was modified with 50 mol% 3-(diethy-
lamino)propylamine (DEP) and subsequently with 50 mol% n-butyla-
mine (B), resulting in a cationic polyaspartamide designated as
DEP50B50. The synthesis was done in the following way (Scheme 1).
2.000 g of PSI (20.62 mmol succinimide unit) was dissolved in 18.0 g of
DMSO and then 1.343 g (10.31 mmol) of DEP was added drop-wise to
the solution. The mixture was stirred at room temperature for 24 h.
0.98 g of n-butylamine (13.40 mmol, in excess) was then added drop-
wise to the solution and the mixture was stirred at room temperature
Scheme 1. Synthesis of DEP50B50 via reacting polysuccinimide (PSI) with 50 mol% 3-(diethylamino)propylamine (DEP) and 50 mol% n-butylamine (B).
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for another 24 h. The polymer was precipitated by adding 300 ml of
ethyl acetate to the reaction mixture, the precipitate was filtered and
washed four times with 50 ml of ethyl acetate, then dried under vacuum
at 25 °C for 24 h. A slightly yellow powder was obtained with an
average yield of 75%. The polymer was stored at room temperature.
1H NMR (500 MHz, DMSO-d6, δ) [ppm]: 4.55 (1H, CO-CH-CH2-CO),
3.06 (4H, NH-CH2-CH2-CH2-N(CH2CH3)2, NH-CH2-CH2-CH2-CH3), 2.65
(2H, CO-CH-CH2-CO), 2.44 (4H, NH-CH2-CH2-CH2-N(CH2CH3)2), 2.37
(2H, NH-CH2-CH2-CH2-N(CH2CH3)2), 1.53 (2H, NH-CH2-CH2-CH2-N
(CH2CH3)2), 1.38 (2H, NH-CH2-CH2-CH2-CH3), 1.24 (2H, NH-CH2-CH2-
CH2-CH3), 0.93 (6H, NH-CH2-CH2-CH2-N(CH2CH3)2), 0.84 (3H, NH-
CH2-CH2-CH2-CH3); FTIR (KBr) [cm
−1]: 3313 (νNH amide), 2965
(νasCH3), 2935 (νasCH2), 1648 (amide I), 1541 (amide II).
Fluorescent marking was used to determine the dissolution rate of
the matrix at the pH of the oral cavity (pH = 6.8). The modification of
PSI with L-tryptophan methyl ester in 1 mol% was done in the same
way as reported earlier [36]. Further steps were carried out in the same
way as for the non-marked polymer DEP50B50. The fluorescent
polymer is designated as T1DEP50B49.
2.2.2. Fabrication of electrospun matrices
Solutions of DEP50B50 in ethanol were prepared at various con-
centrations (20, 25 and 30 wt%) for electrospinning, with the resulting
matrices denoted as M20, M25 and M30. A homemade electrospinning
instrument equipped with a high voltage DC supply (MA 2000 NT-35)
was used to electrospin the DEP50B50 polymer. A grounded plate
covered with aluminum foil was used as collector. The applied voltage
was 20 kV, and the distance of the spinneret from the collector was
15 cm in each case. The polymer solutions were filled in a syringe and
dosed by a syringe pump (Harvard Apparatus). The volume rate was set
to 0.5 ml h−1. The product was a white, thin, random mesh. The ex-
periments were carried out at ambient temperature and the relative
humidity was 50%. The same conditions were applied during storage of
the matrices.
In vitro matrix dissolution and drug release in simulated salivary
fluid (pH = 6.8) were studied by using the fluorescently marked
polymer (T1DEP50B49) [36] and vitamin B12 as a model drug. Prior to
electrospinning, 5 mg of vitamin B12 was dissolved in 0.71 g solution of
T1DEP50B49 (25 wt% polymer in ethanol). The matrices were prepared
in the same way as those without the drug. 10 mg of the final solid
matrix contained 250 µg vitamin B12.
Besides the electrospun matrices, free films were prepared by eva-
poration of the ethanol from their solutions. The given solution was
poured onto a glass plate bordered with a 1 mm thick silicone frame.
The coated plate was dried at room temperature for 48 h under 50%
relative humidity. Finally, the film was peeled off from the substrate.
The concentration of the polymer was 25 wt% in its ethanol solution,
while in the drug release study the final concentration of vitamin B12 in
the solid film was the same as in the electrospun matrices.
2.3. Characterization
2.3.1. Physico-chemical characterization
1H NMR spectra of the polymers were recorded using a Bruker
500 MHz spectrometer with 128 scans in DMSO‑d6 (3 wt% polymer
solution). TMS (0.03 vol%) was used as internal standard. FTIR spectra
were recorded using a Bruker Tensor 27 FTIR spectrometer on KBr
pellets (1.5 mg polymer or fibrous matrix/250 mg KBr) from 4000 to
400 cm−1 with 128 scans and a resolution of 2 cm−1 for each sample.
The density of the dry polyaspartamide, DEP50B50 was determined by
helium pycnometry (Ultrapycnometer 1000, Quantachrome). This
value was used for the calculation of the specific surface area (SSA) of
the resulting matrices (Supplementary Data).
The polymer solutions were characterized by measuring their visc-
osity, surface tension and conductivity. DEP50B50 was dissolved in
ethanol at concentrations of 15, 20, 25, 30 and 35 wt%. The viscosity of
the polymer solutions was determined with a rolling ball viscometer
(Lovis 2000, Anton Paar) coupled with a density meter (DMA 4500 M,
Anton Paar). The viscosity measurements were carried out at an angle
of 45°. The diameters of the capillary and the ball used were 1.59 mm
and 1.5 mm, respectively. The surface tension of the solutions was
determined by using a drop shape analysis system (DSA-30, Kruss). A
pendant droplet of the solution was formed at the end of a syringe fixed
vertically, and an image was taken at the moment when the drop
snapped from the apex of the syringe. The surface tension was calcu-
lated from the shape of the drop as described elsewhere [33]. A con-
ductometer (inoLab Level 2, WTW) equipped with a conductivity cell
(Tectracon 325, WTW) was used to determine the specific conductivity
of the polymer solutions at 25 °C.
2.3.2. Scanning electron microscopy
The morphology of the samples was investigated with a Carl Zeiss
Merlin field-emission high-resolution scanning electron microscope
(SEM). A conducting layer with a thickness of 15 nm was applied by
cathode sputtering using a (80/20) Au/Pd alloy. Images were recorded
with 5 kV accelerating voltage (300 pA). The characteristic size of the
fibers was determined by JMicroVision V.1.2.7 image analysis software,
the average value was calculated from at least 200 fibers per sample.
Calculation of the specific surface area (SSA) of the matrices can be
found in the Supplementary Data.
2.3.3. Thermal analysis (TGA, DSC) and X-ray diffraction (XRD)
Thermogravimetric analysis of the DEP50B50 polymer and the
matrices was carried out with a PerkinElmer Simultaneous Thermal
Analyser. Samples of about 10 mg were heated from 30 to 600 °C at a
scanning rate of 10 °C min−1 under N2 atmosphere.
The glass transition temperature (Tg) of the matrices was de-
termined by differential scanning calorimetry (DSC). DSC traces were
recorded with a PYRIS Diamond Differential Scanning Calorimeter
(PerkinElmer). Two heating and one cooling run were performed on
10 mg samples in N2 atmosphere with a heating and cooling rate of
10 °C min−1 between −60 and 120 °C. The first heating-cooling cycle
was used to erase the thermal history and remove residual organic
solvent as well as moisture. DSC curves recorded in the second heating
run were used to determine the Tg of the samples.
Powder XRD patterns were measured by a PANalytical X’pert Pro
MPD X-ray diffractometer (Malvern Panalytical Ltd.) using Cu Kα ra-
diation (α1 = 1.5406 λ, α2 = 1.5444 λ). Each sample was scanned at
40 kV and 30 mA in the 2ϴ interval 5–65° at scanning rate 0.1°/s with
step size 0.010°.
2.3.4. Matrix dissolution and drug release studies
A piece of the drug loaded matrix (10 mg) was immersed in 20 ml of
SSF (pH = 6.8, T = 37 °C). The measurements were carried out in a
continuously stirred vessel (V = 50 ml, stirring rate: 200 rpm, Fig. S1,
Supplementary Data). Samples of 2 ml were taken at predetermined
time intervals, and replaced with 2 ml fresh SSF. The experiment was
performed in triplicate, and the averaged results were used for eva-
luation. The amount of dissolved T1DEP50B49 was determined by
fluorescence spectroscopy (PerkinElmer LS55 fluorescence spectro-
meter; λext: 270 nm; λem: 350 nm). The concentration of released vi-
tamin B12 was measured by UV–Vis spectrophotometry (Jena Specord
200 UV–Vis spectrophotometer, λabs = 361 nm [48], Fig. S2,
Supplementary Data). Dissolution rate constant of the polyaspartamides
at given pH was calculated by the Noyes–Whitney equation [49], (1):
=
c
c
e1
t kt
(1)
where ct is the concentration of the dissolved polymer at time t and c is
the concentration of the dissolved polymer at infinite time (20 min in
our experiments), k is the dissolution rate constant. The Noyes–Whitney
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equation was also applied to describe the drug release profiles.
Results of the dissolution and release tests were analyzed statisti-
cally with GraphPad Prism software (version 5). Two-way ANOVA
(with Bonferroni post-tests) analysis was applied. The results are ex-
pressed as mean values ± standard deviation (SD). A level of p≤ 0.05
was taken as significant, p≤ 0.01 as very significant, and p≤ 0.001 as
highly significant.
3. Results and discussion
3.1. Effect of the polymer composition
Our aim was to prepare electrospun matrices of polyaspartamides
that provide rapid drug release in the oral cavity. Ethanol was chosen as
a green and pharmaceutically accepted solvent [13], as an alternative
to the toxic or hazardous solvents often used in electrospinning. Polar
drug molecules with low aqueous solubility are often soluble and stable
in ethanol [50], which has a relatively high dielectric constant and
evaporates easily [8]. However, the use of ethanol with no additives for
electrospinning has been reported only for a limited number of poly-
mers [9,18–24]. Polyaspartamides were prepared by modifying PSI
with dialkylaminoalkyl [2-(dimethylamino)ethyl, 2-(diethylamino)
ethyl, 3-(dimethylamino)propyl, 3-(diethylamino)propyl] groups to
introduce cationic character into the polymer. The presence of dialky-
laminoalkyl side groups ensures good solubility of the polyaspartamides
in ethanol and in water over a wide pH range (pH 1–9) [36]. The large
specific surface area (1–10 m2 g−1) facilitates the moisture uptake of
the matrices, which can be reduced by introducing alkyl side groups.
Accordingly, the polymers were modified with alkyl side groups (n-
propyl, n-butyl, n-hexyl), in addition to cationic groups, to control the
solubility and water uptake. The type and molar ratio of different side
groups was selected by electrospinning of the polymer solutions and by
the examination of the matrices produced (Fig. 1). The size of the fibers
formed from polymers with n-propyl side groups varied over a wide
range, while the aqueous solubility of the matrices prepared from
polyaspartamides containing n-hexyl ligands was poor (Fig. 1d); for this
reason n-butyl side groups were used in further experiments. Poly-
aspartamides containing more than 75 mol% of alkyl side groups were
poorly soluble at the pH of saliva (pH = 6.8), and moisture uptake
decreased, but fibers stuck together and beads were observed (Fig. 1b).
The type of cationic groups also had a significant effect on fiber for-
mation and moisture uptake. Increasing the alkylene chain length from
ethylene (DME, DEE) to propylene (DMP, DEP) the fiber formation
improved. Fibers formed with smaller size (diameter or width and
thickness) and narrower size distribution (Fig. 1a). Moisture uptake of
the matrix decreased with increasing the chain length of N-alkyl side
groups (Fig. 1c) but matrices prepared from polyaspartamides con-
taining more than 50 mol% (dimethylamino)alkyl side group (DME,
DMP) or more than 75 mol% (diethylamino)alkyl side group (DEE,
DEP) were hygroscopic, which makes their storage difficult. Finally,
polyaspartamide containing 50 mol% DEP and 50 mol% B groups
(DEP50B50) was selected, as this polymer forms fibers in the range of a
few hundred nanometers from which fast dissolution was expected.
The chemical structure of PSI and DEP50B50 was confirmed by 1H
NMR (Fig. S3, Supplementary Data) and FTIR spectroscopy. The results
of MTT proliferation assay performed on PC3 cells (Fig. S4,
Supplementary Data), along with our study on the biocompatibility of
cationic polyaspartamides [43], are in support of human biological use
of DEP50B50.
3.2. Preparation of DEP50B50 fibers
According to the literature data and our results, fiber formation
strongly depends on the chemical structure of the polymer [12]. The
morphology of the prepared fibers also depends on the properties of the
polymer solution, especially the viscosity, the surface tension and the
conductivity [6]. These characteristics were determined over a wide
concentration range to find the optimal composition of the polymer
solution for electrospinning (Fig. 2).
The accelerating force of the electric field must permanently over-
come the force arising from the surface tension of the solution to obtain
fibrous morphology. The surface tension of the solution remains prac-
tically unchanged with increasing the polymer concentration (Fig. 2a)
and is similar to that of the solvent (21.9 mN m−1) [20]. Only a very
slight increase was observed at large concentrations, and hence the
polymer can be considered as capillary-inactive in ethanol. Similar
behavior was observed for another polyamide type polymer, nylon 6 in
formic acid [51]. The viscosity and conductivity depend strongly on the
Fig. 1. Effect of the polymer composition on the fiber formation and the properties of the electrospun matrices: (a) increasing alkylene chain length, (b) incorporating
alkyl side groups, (c) increasing N-alkyl chain length, (d) increasing alkyl chain length.
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concentration of the polymer (Fig. 2b). The lowest concentration and
corresponding dynamic viscosity suitable for electrospinning were
found to be 20 wt% and 13 mPas, respectively. The large specific
conductivity at 15 wt% concentration should lead to jet formation [12],
but the polymer fibers broke into droplets before reaching the collector
because of the low viscosity and incomplete solvent evaporation. In-
creasing the concentration of the DEP50B50 polymer to 20, 25 or 30 wt
% increases the viscosity of the solution, thereby making the electro-
spinning feasible, thus fibrous matrices were electrospun. At 35 wt%
concentration, however, fibers did not form owing to the decreased
conductivity, since the electrostatic force exerted by the electric field is
insufficient to overcome the forces from the surface tension and the
greatly increased dynamic viscosity (35 wt%, 279 mPas). Although the
conductivity can be increased by adding inorganic salts, we did not
perform additional experiments at high polymer concentrations, since
the use of an additive requires an undesirable removal step after fiber
formation. As a result, in the subsequent experiments, DEP50B50
ethanol solutions with polymer concentrations between 20 and 30 wt%
were used for electrospinning. The voltage of 20 kV and the flow rate of
0.5 ml h−1 were found to be appropriate for preparing fibers in the
chosen concentration range. Details of the electrospinning and the so-
lution parameters are listed in Table 1.
3.3. Characterization of the electrospun fibers
3.3.1. Morphology
The size and shape of the fibers vary considerably with polymer
concentration, as shown in Fig. 3. Nanofibers electrospun from 20 wt%
solution (M20) are stuck together and contain beads (Fig. 3a). This can
be explained by incomplete evaporation of the solvent before the
polymer reaches the surface of the collector [6]. Although the specific
surface area of the M20 fibers is found to be quite large (9.4 m2 g−1,
Table 1), the size distribution of the fiber diameter is rather wide [PDI:
0.22 (PDI: polydispersity index of fiber diameter, Supplementary Data)]
and cylindrical fiber diameter varies between 100 nm and 1 µm
(Fig. 3a). Electrospinning from a 25 wt% solution yielded ribbon-like
fibers without beads having a submicron size with a narrow size dis-
tribution of the fiber thickness (mean size, d = 335 ± 71 nm,
PDI = 0.02) and width (d = 743 ± 112 nm, PDI = 0.04) (Fig. 3b).
The ribbon-like shape of the fibers can be explained by various factors,
such as the high vapor pressure of the solvent employed (ethanol in the
present case) [52], while the shape also depends on the polymer con-
centration, or on the structure of the polymer itself [52–54]. The spe-
cific surface area calculated (7.7 m2 g−1, Table 1.) remained suffi-
ciently large to provide rapid dissolution of the M25 matrix in an
Fig. 2. (a) Surface tension and (b) dynamic viscosity and specific conductivity of the ethanol solutions as a function of the DEP50B50 concentration (curves are to
guide the eye).
Table 1
Details of the preparation and the morphological properties of DEP50B50 fibers.
Sample code ca (wt%) ρb (g cm−3) ηc (mPas) γd (mNm−1) κe (µS cm−1) Uf (kV) V̇g (ml h−1) rh (cm) di (nm) SSAj (m2g−1) Tg
k (°C)
width thickness
M15 15 0.830 6 21.7 37.7 20 0.5 15 – – –
M20 20 0.844 13 22.0 35.4 20 0.5 15 397 ± 179
(cylindrical fibers)
9.4 48
M25 25 0.859 30 22.0 30.5 20 0.5 15 743 ± 112 335 ± 71 7.7 49
(ribbons)
M30 30 0.876 89 22.5 24.8 20 0.5 15 1728 ± 294 1007 ± 171 2.8 51
(ribbons)
M35 35 0.893 279 23.2 18.4 20 0.5 15 – – –
a Concentration.
b Density.
c Dynamic viscosity.
d Surface tension.
e Specific conductivity of the DEP50B50 ethanol solutions at 25 °C.
f Applied voltage.
g Flow rate.
h Distance between the spinneret and the collector.
i Size (diameter or width and thickness) of the fibers with standard deviation.
j Specific surface area of the matrices, ρDEP50B50 = 1.12 g cm
−3.
k Glass transition temperature.
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appropriate solvent. Fibers electrospun from a 30 wt% solution (M30)
also display ribbon-like morphology, but the thickness
(d = 1007 ± 171 nm) and the width (d = 1728 ± 294 nm) of the
fibers are larger than in the previous case (Fig. 3c). The increase in size
can be explained by the high viscosity and the reduced specific con-
ductivity (Fig. 2b). This microfibrous morphology yields a decreased
specific surface area (2.8 m2 g−1, Table 1). In conclusion, 25 wt% was
found to be the ideal concentration of the DEP50B50 and T1DEP50B49
polymers for preparing fibers in the submicron size range with a narrow
size distribution. It is important to emphasize that, contrary to ex-
amples reported in the literature [53], the matrices were prepared with
no additives. This can be explained by the high dielectric constant of
the solvent, which prevents the formation of beads [55].
3.3.2. Stability and thermal properties
FTIR spectroscopy was used to characterize the effect of electro-
spinning on the chemical structure of the DEP50B50 polymer. Fig. 4a
presents the FTIR spectra of the DEP50B50 polymer and the prepared
M25 matrix. IR bands assigned to the polymer backbone (amide I.:
1648 cm−1, amide II.: 1541 cm−1) and to the side groups of DEP50B50
(νCH2: 2935 cm
−1, νCH3: 2965 cm
−1) attest to the presence of all the
expected functional groups. Additionally, the characteristic absorption
band of the imide ring at around 1718 cm−1 is not present in the
spectra of polyaspartamides, proving that ring-opening of the succini-
mide repeating units was complete [36]. More importantly, the two
spectra match each other perfectly, showing that the polymer does not
suffer chemical degradation during electrospinning.
The thermal decomposition of the DEP50B50 and the M25 matrix
was determined in the temperature range from 30 to 600 °C by
Fig. 3. SEM micrographs and fiber size distribution of matrices electrospun from DEP50B50 ethanol solutions at concentrations of (a) 20 wt% (M20), (b) 25 wt%
(M25) and (c) 30 wt% (M30), respectively.
Fig. 4. (a) FTIR spectra and (b) TGA curves of the DEP50B50 polymer and the M25 matrix.
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thermogravimetric analysis (TGA). Weight loss occurs below 100 °C due
to the elimination of solvents (residual ethanol, absorbed water,
~5–6 wt%). Both the polymer and the electrospun matrix decompose
around 200 °C (Fig. 4b). This relatively high thermal decomposition
temperature (Td) enables to process these polymers at high tempera-
tures. For instance, the matrix can be sterilized using dry heat (com-
monly carried out in the temperature range of 160–180 °C), or polymer
processing by melt extrusion or melt electrospinning can be also fea-
sible without chemical decomposition.
DSC measurements were made on the electrospun matrices (M20,
M25, M30) and on a free film prepared from DEP50B50 (F25) and
compared to each other (Fig. 5). As a reference, the DSC trace of vi-
tamin B12 (B12) is also plotted indicating the absence of any peak or step
in the temperature range of 0–80 °C. The glass transition temperature
(Tg) of the polymers is detected in the temperature range of 48–52 °C
for both the free film and the fibrous matrices. A slight suppression of Tg
with decreasing fiber diameter (and increasing specific surface area)
was observed, which result corresponds to the theoretical and the ex-
perimental predictions of the literature [56,57]. Nevertheless, large
size-dependent suppression in the Tg is typical in the case of polymer
fibers with smaller diameter. In our case, the electrospinning does not
have a significant effect on the Tg. The almost identical Tg of the M25T
and M25 matrices prove that fluorescent marking does not affect glass
transition temperature either. However, the Tg of the M25 matrix
containing B12 (M25/B12) was slightly lower than that of the M25
matrix, but considering the wide temperature range of the glass tran-
sition the difference is not significant. Since the glass transition tem-
perature of the electrospun matrices is higher than the room tempera-
ture (~50 °C), the matrices are in glassy state, i.e., the motion of chain
segments is frozen at room temperature. The glassy state can hinder the
crystallization of the loaded material, which is important for the future
application of the matrix in the formulation of crystalline drugs.
X-ray diffraction is generally used to analyze the prepared matrices
with respect to the crystallinity of the polymer and the loaded drug. In
consistency with the results of the thermal analysis, no reflection peaks
of a crystalline phase could be observed in the diffractograms (Fig. S5,
Supplementary Data), demonstrating that the vitamin B12, the pure
DEP50B50 matrix, and the matrix loaded with the model drug are
amorphous. This property can ensure the fast dissolution of the matrix
and rapid release of the model drug.
3.3.3. Matrix dissolution and drug release
Fast dissolution of the matrix is required to exploit the advantage of
sublingual and buccal drug delivery. The dissolution profile of the
T1DEP50B49 polyaspartamide matrix and the release of vitamin B12
were determined at the pH of saliva (6.8) and at physiological tem-
perature (37 °C). T1DEP50B49 as a polymer labeled with fluorescent
tryptophan methyl ester was used to monitor the dissolution of the
matrix. This method was applied successfully earlier for poly(aspartic
acid) derivatives with alkyl side groups [35] and cationic poly-
aspartamides [36]. We chose vitamin B12 as a model drug for several
reasons: a) it is soluble in ethanol (≥1 g/L) [58], the solvent we used
for electrospinning, b) vitamin B12 has high aqueous solubility
(12–14 g/L) [59], c) its detection is easy by UV–VIS spectroscopy, and
d) oral administration of vitamin B12 (including sublingual) is wide-
spread, especially in the treatment of vitamin B12 deficiency [60]. As
vitamin B12 is highly soluble in saliva and typically used in very low,
1–1000 µg, doses in the formulations [60], the role of the polymer
matrix is to facilitate the handling of the active compound for both the
production and the patients as well as to ensure rapid release of in-
corporated vitamin B12. Vitamin B12 was incorporated in the fibers
during electrospinning (see photo in Fig. 6a of a T1DEP50B49 matrix
loaded with vitamin B12). As noted in Fig. 6b, more than 82% of the
T1DEP50B49 matrix (M25T) was dissolved, while 90% of vitamin B12
(B12,M) was released in the first minute of the experiment, indicating
that the fast dissolution of the matrix (kM25T = 2.2 min
−1) is accom-
panied by the rapid release of vitamin B12 (kB12,M = 2.5 min
−1) in-
corporated. To characterize the effect of formulation on the release of
vitamin B12, the dissolution profile of the pure vitamin B12 (B12) and the
release of vitamin B12 incorporated in a T1DEP50B49 film (B12,F) were
also determined at the pH of saliva (pH = 6.8). As shown in Fig. 6c,
there is no significant difference between the dissolution profile of the
pure vitamin B12 (B12) and the release profile of vitamin B12 in-
corporated in the nanofibrous matrix (B12,M) (p > 0.05). However, the
Fig. 5. DSC traces of DEP50B50 film (F25), DEP50B50 matrices (M20, M25,
M30), a matrix made of T1DEP50B49 (M25T), DEP50B50 matrix loaded with
vitamin B12 (M25/B12), and the pure vitamin B12 (B12).
Fig. 6. (a) Photograph of the T1DEP50B49 matrix loaded with vitamin B12 (M25T/B12), (b) dissolution of the T1DEP50B49 matrix (M25T) and rapid release of
vitamin B12 from this matrix (B12,M), and (c) dissolution profile of the pure vitamin B12 (B12), and release profiles of vitamin B12 from T1DEP50B49 matrix (B12,M) and
T1DEP50B49 film (B12,F) (SSF, pH = 6.8, 37 °C).
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release of vitamin B12 entrapped in a film (B12,F) was significantly
slower than that from the T1DEP50B49 matrix (B12,M) (p < 0.001,
highly significant) over the entire time range. B12 and B12,M dissolves
almost completely (≥90%) within one minute, while release of B12,F is
only just above 50% in that time. Dissolution rate constants calculated
by the Noyes–Whitney equation (Eq. (1)) are in agreement with this
observation (kB12 = 2.6 min
−1, kB12,M = 2.5 min
−1,
B12,F = 1.6 min
−1).
4. Conclusion
Nanofibrous matrices were successfully prepared from a cationic
polyaspartamide containing 50 mol% 3-(diethylamino)propyl and
50 mol% n-butyl side groups by solvent electrospinning using ethanol, a
green and pharmaceutically accepted solvent (ICH 3 Class solvent).
Matrices were produced with no additives, and submicron sized fibers
with a narrow size distribution were achieved with a polymer con-
centration of 25 wt%. Both the polymer and the fibrous matrices have a
high thermal decomposition temperature (200 °C) and a glass transition
temperature at around 50 °C. The matrix dissolved almost completely
within one minute in simulated salivary fluid (pH = 6.8), which was
accompanied by the rapid release of vitamin B12 incorporated. These
results suggest the potential application of electrospun matrices of
polyaspartamides in sublingual and buccal drug delivery.
5. Data availability statement
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